Narayana Hrudayalaya Ltd. (IN:NH)
:NH
Top Page
Narayana Hrudayalaya Ltd.
(NH)
Select Model
Select Model
Rating:71Outperform
Price Target:
₹1,795.00
▲(2.19% Upside)
Action:ReiteratedDate:11/18/25
Narayana Hrudayalaya Ltd. has a strong financial performance with robust revenue growth and profitability, which is the most significant factor in its overall score. The technical analysis indicates bullish momentum, although the stock appears overvalued based on its P/E ratio. The absence of earnings call data and corporate events limits further insights.
Positive Factors
Sustained revenue growth
The company’s revenue more than doubled from 25.8bn in 2021 to 54.8bn in 2025, indicating sustained demand and market expansion. Durable top-line growth supports higher utilization of fixed hospital assets, long-term operating leverage, and predictable cash generation for reinvestment.
Negative Factors
Rising total debt
An increasing debt load over multiple years erodes financial flexibility and raises interest and refinancing exposure. If leverage continues upward it can constrain capital allocation, increase funding costs in a higher‑rate environment, and magnify downside risk during margin pressure.
Read all positive and negative factors
Positive Factors
Negative Factors
Sustained revenue growth
The company’s revenue more than doubled from 25.8bn in 2021 to 54.8bn in 2025, indicating sustained demand and market expansion. Durable top-line growth supports higher utilization of fixed hospital assets, long-term operating leverage, and predictable cash generation for reinvestment.
Read all positive factors
Narayana Hrudayalaya Ltd. (NH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹331.90B
Dividend Yield0.24%
Average Volume (3M)80.08K
Price to Earnings (P/E)75.8
Beta (1Y)0.80
Revenue Growth14.72%
EPS Growth8.37%
CountryIN
Employees11,659
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)6.30
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio92.72
Price to Book (P/B)9.40
Price to Sales (P/S)6.22
P/FCF Ratio-354.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,130.00Price Target Upside21.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)53.4
Revenue Forecast (FY)₹101.48B
Narayana Hrudayalaya Ltd. Business Overview & Revenue Model
Company Description
Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiol...
How the Company Makes Money
Narayana Hrudayalaya Ltd. primarily makes money by delivering healthcare services to patients through its owned/operated hospitals and clinics. Revenue is generated mainly from (1) inpatient services: hospital admissions, bed/room charges, intensi...
Narayana Hrudayalaya Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.93B | 54.83B | 48.90B | 45.30B | 37.01B | 25.84B |
| Gross Profit | 25.76B | 21.12B | 18.41B | 16.76B | 12.13B | 6.42B |
| EBITDA | 13.77B | 12.28B | 11.02B | 9.31B | 6.19B | 1.43B |
| Net Income | 8.45B | 7.90B | 7.89B | 6.06B | 3.42B | -143.04M |
Balance Sheet | ||||||
| Total Assets | 77.42B | 72.65B | 56.25B | 41.62B | 31.30B | 27.70B |
| Cash, Cash Equivalents and Short-Term Investments | 18.24B | 16.27B | 11.04B | 6.51B | 3.01B | 2.39B |
| Total Debt | 23.40B | 24.28B | 16.27B | 8.84B | 7.23B | 8.26B |
| Total Liabilities | 36.80B | 36.37B | 27.39B | 20.30B | 16.40B | 16.49B |
| Stockholders Equity | 40.60B | 36.26B | 28.84B | 21.31B | 14.89B | 11.20B |
Cash Flow | ||||||
| Free Cash Flow | 4.14B | -961.81M | 959.93M | 5.63B | 2.34B | 2.39B |
| Operating Cash Flow | 6.90B | 9.86B | 10.67B | 10.85B | 4.85B | 3.09B |
| Investing Cash Flow | -5.24B | -13.25B | -14.58B | -11.74B | -2.67B | -1.13B |
| Financing Cash Flow | -2.09B | 5.44B | 4.88B | 877.41M | -1.59B | -1.98B |
Narayana Hrudayalaya Ltd. Technical Analysis
Negative
1756.45
Price Trends
1753.71
Negative
1826.05
Negative
1838.73
Negative
Market Momentum
-42.80
Positive
39.64
Neutral
36.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NH, the sentiment is Negative. The current price of 1756.45 is above the 20-day moving average (MA) of 1682.66, above the 50-day MA of 1753.71, and below the 200-day MA of 1838.73, indicating a bearish trend. The MACD of -42.80 indicates Positive momentum. The RSI at 39.64 is Neutral, neither overbought nor oversold. The STOCH value of 36.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:NH.
Narayana Hrudayalaya Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ₹775.92B | 18.87 | ― | 0.33% | 7.33% | -3.79% | |
71 Outperform | ₹331.90B | 75.82 | ― | 0.24% | 14.72% | 8.37% | |
67 Neutral | ₹78.91B | -247.47 | ― | ― | 17.58% | -38.20% | |
65 Neutral | ₹250.55B | 114.01 | ― | ― | 25.74% | 1.41% | |
65 Neutral | ₹269.07B | 83.79 | ― | 0.04% | 15.78% | 15.01% | |
61 Neutral | ₹595.51B | 86.12 | ― | 0.11% | 15.33% | 54.62% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:NH
Narayana Hrudayalaya Ltd.
1,685.35
46.86
2.86%
IN:AUROPHARMA
Aurobindo Pharma Ltd
1,339.80
248.80
22.80%
IN:FORTIS
Fortis Healthcare Ltd.
808.10
176.50
27.94%
IN:HCG
HealthCare Global Enterprises Ltd.
538.55
21.65
4.19%
IN:KIMS
Krishna Institute of Medical Sciences Limited
626.20
56.85
9.99%
IN:MEDANTA
Global Health Limited
1,033.70
-161.67
-13.52%
Narayana Hrudayalaya Ltd. Corporate Events
Narayana Hrudayalaya shareholders and creditors back scheme of arrangement
Apr 3, 2026
Narayana Hrudayalaya Ltd. has disclosed the voting results and scrutinizer’s report for the National Company Law Tribunal-convened meetings of its equity shareholders, secured creditors and unsecured creditors held on April 2, 2026 via video...
Narayana Hrudayalaya shareholders and creditors back scheme of arrangement with near-unanimous vote
Apr 3, 2026
Narayana Hrudayalaya Ltd. has reported the voting outcomes of court-convened meetings of its equity shareholders, secured creditors and unsecured creditors held on April 2, 2026 via video conferencing, as directed by the National Company Law Tribu...
Narayana Hrudayalaya Schedules Investor Meeting With Key Institutional Funds
Mar 25, 2026
Narayana Hrudayalaya Ltd. has announced that its management will meet with analysts and institutional investors representing Premji, Magma and Arohi in a group, in-person meeting arranged by ICICI Securities on March 27, 2026, at 10:30 a.m. IST. T...
Narayana Hrudayalaya Lines Up Full-Day Investor Meetings on March 23, 2026
Mar 21, 2026
Narayana Hrudayalaya has scheduled a series of investor and analyst meetings on March 23, 2026, in Mumbai, as disclosed under Indian listing regulations. The sessions will run from 10 a.m. to 5 p.m. IST and are intended to engage a broad base of i...
Narayana Hrudayalaya Creates UK Property Arm to Support Hospital Expansion
Mar 13, 2026
Narayana Hrudayalaya’s wholly owned step-down subsidiary, Narayana Hrudayalaya UK Ltd., has incorporated a new private company in the United Kingdom, Practice Plus Group Property Ltd., with a paid-up share capital of GBP 1,000 to function as...
Narayana Hrudayalaya Sets April 2026 Creditor and Shareholder Meetings for Restructuring Scheme
Feb 26, 2026
Narayana Hrudayalaya has scheduled meetings of its shareholders and secured and unsecured creditors, alongside those of NH Integrated Care Private Limited, on 2 April 2026 via video conferencing, as directed by the National Company Law Tribunal in...
Narayana Hrudayalaya Sets April Meetings on NH Integrated Care Demerger Scheme
Feb 26, 2026
Narayana Hrudayalaya Ltd. has scheduled meetings of its shareholders and secured and unsecured creditors, along with those of NH Integrated Care Private Limited, on April 2, 2026, following directions from the National Company Law Tribunal’s...
Narayana Hrudayalaya Publishes NCLT Notice on Merger of Meridian Medical Research & Hospital
Feb 7, 2026
Narayana Hrudayalaya Limited, a leading hospital and healthcare services provider, operates through a network of medical institutions and subsidiaries across India, offering a range of clinical and research-focused healthcare services.The company ...
Narayana Hrudayalaya Shareholders and Creditors Clear Scheme of Arrangement with Meridian Medical Research & Hospital
Jan 21, 2026
Narayana Hrudayalaya Limited has reported the voting results and Scrutinizer’s Report for National Company Law Tribunal-convened meetings of its equity shareholders, secured creditors, unsecured loan creditors and unsecured trade creditors h...
Narayana Hrudayalaya Forms Wholly Owned Subsidiary to Drive Northern India Expansion
Jan 16, 2026
Narayana Hrudayalaya Ltd. has incorporated a new wholly owned subsidiary, Narayana Healthcare North Private Limited, with an authorised capital of Rs 10 lakh and paid-up capital of Rs 5 lakh, to operate in the hospital and healthcare sector. The s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.